Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Aug 31, 2025 | (Q4)Aug 31, 2025 | (Q3)May 31, 2025 | (Q2)Feb 28, 2025 | (Q1)Nov 30, 2024 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 335.55%86.58K | 509.88%38.23K | 3,501.14%22.08K | 19.42%15.52K | 10.76K | 8,696.02%19.88K | 6.27K | 613 | 13K | 0 |
| Gross profit | -335.55%-86.58K | -509.88%-38.23K | -3,501.14%-22.08K | -19.42%-15.52K | -10.76K | -8,696.02%-19.88K | -6.27K | -613 | -13K | 0 |
| Operating expense | 309.55%16.87M | 1,446.16%6.36M | 247.95%5.58M | 139.44%2.53M | 102.31%2.13M | 124.35%4.12M | -48.93%411.46K | 354.37%1.6M | 213.36%1.05M | 208.70%1.05M |
| Selling and administrative expenses | 255.67%5.33M | 196.00%1.67M | 1,113.42%1.62M | 799.72%831.23K | 160.31%721.28K | 122.69%1.5M | 488.18%565.07K | -31.33%133.57K | -51.62%92.39K | 44.53%277.09K |
| -Selling and marketing expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -75.90%11.6K | 213.21%82.42K | ---- |
| -General and administrative expense | 255.67%5.33M | 196.00%1.67M | 1,113.42%1.62M | 799.72%831.23K | 160.31%721.28K | 122.69%1.5M | 155.62%565.07K | -8.75%133.57K | -43.89%92.39K | 96.25%277.09K |
| Other operating expenses | 340.38%11.54M | 3,152.90%4.69M | 169.24%3.95M | 76.04%1.69M | 81.55%1.41M | 125.31%2.62M | -121.65%-153.6K | 828.93%1.47M | 560.93%962.19K | 420.26%774K |
| Operating profit | -309.68%-16.96M | -1,432.11%-6.4M | -249.19%-5.6M | -137.98%-2.54M | -103.34%-2.14M | -125.41%-4.14M | 48.17%-417.73K | -354.55%-1.6M | -217.22%-1.07M | -208.00%-1.05M |
| Net non-operating interest income (expenses) | 4,722.51%379.05K | 4,818.82%386.62K | -7.57K | 132.15K | 14.94K | 7.86K | 7.86K | 0 | 0 | 0 |
| Non-operating interest income | 4,928.38%395.23K | ---- | ---- | --132.15K | --14.94K | --7.86K | ---- | ---- | --0 | --0 |
| Non-operating interest expense | --16.18K | --8.61K | --7.57K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Other net income (expenses) | 33.92%84.59K | -244.78K | 184.21K | -169.91K | -114.57K | 129.13%63.17K | ||||
| Gain on sale of security | 272.15%4.85K | ---245.7K | --105.38K | ---- | ---1.93K | -194.43%-2.82K | ---- | ---- | ---- | ---- |
| Special income (charges) | --0 | ---- | ---- | ---169.91K | ---112.64K | 160.09%63.95K | ---- | ---- | --0 | --0 |
| -Less:Impairment of capital assets | --0 | ---- | ---- | ---- | ---- | ---63.95K | ---- | ---- | ---- | ---- |
| -Less:Write off | ---- | ---- | ---- | --169.91K | --112.64K | ---- | ---- | ---- | --0 | --0 |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 3,824.61%79.75K | --919 | --78.83K | ---- | ---- | --2.03K | ---- | ---- | ---- | ---- |
| Income before tax | -305.43%-16.49M | -1,705.08%-6.26M | -238.17%-5.42M | -141.51%-2.58M | -112.82%-2.24M | -124.92%-4.07M | 55.46%-346.7K | -354.55%-1.6M | -217.22%-1.07M | -208.00%-1.05M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -305.43%-16.49M | -1,705.08%-6.26M | -238.17%-5.42M | -141.51%-2.58M | -112.82%-2.24M | -124.92%-4.07M | 55.46%-346.7K | -354.55%-1.6M | -217.22%-1.07M | -208.00%-1.05M |
| Net income continuous operations | -305.43%-16.49M | -1,705.08%-6.26M | -238.17%-5.42M | -141.51%-2.58M | -112.82%-2.24M | -124.92%-4.07M | 55.46%-346.7K | -354.55%-1.6M | -217.22%-1.07M | -208.00%-1.05M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -305.43%-16.49M | -1,705.08%-6.26M | -238.17%-5.42M | -141.51%-2.58M | -112.82%-2.24M | -124.92%-4.07M | 55.46%-346.7K | -354.55%-1.6M | -217.22%-1.07M | -208.00%-1.05M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -305.43%-16.49M | -1,705.08%-6.26M | -238.17%-5.42M | -141.51%-2.58M | -112.82%-2.24M | -124.92%-4.07M | 55.46%-346.7K | -354.55%-1.6M | -217.22%-1.07M | -208.00%-1.05M |
| Diluted earnings per share | -166.67%-0.24 | -0.08 | -100.00%-0.08 | -33.33%-0.04 | -33.33%-0.04 | -50.00%-0.09 | 0 | -700.00%-0.04 | -189.07%-0.03 | -165.06%-0.03 |
| Basic earnings per share | -166.67%-0.24 | -1,063.97%-0.08 | -100.00%-0.08 | -33.33%-0.04 | -33.33%-0.04 | -50.00%-0.09 | 31.27%-0.0069 | -700.00%-0.04 | -189.07%-0.03 | -165.06%-0.03 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.